Selective cognitive impairments associated with NMDA receptor blockade in humans

Neuropsychopharmacology

Volumn 30, Issue 3, 2005, Pages 633-639

  Rowland, Laura H ^a,e   Astur, Robert S ^b   Jung, Rex E ^c   Bustillo, Juan R ^c,d   Lauriello, John ^c,d   Yeo, Ronald A ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Ketamine; Learning; Memory; Morris water maze; NMDA receptor; Schizophrenia; Spatial navigation

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO;

ADULT; ARTICLE; ATTENTION; BEHAVIOR; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; INFORMATION RETRIEVAL; LEARNING; LEARNING DISORDER; LONG TERM POTENTIATION; MALE; MAZE TEST; MEMORY; MORRIS WATER MAZE TEST; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; RECEPTOR BLOCKING; SCHIZOPHRENIA; SPATIAL DISCRIMINATION; SPATIAL NAVIGATION; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; VERBAL BEHAVIOR; VERBAL MEMORY; WORKING MEMORY;

COGNITION DISORDERS; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; KETAMINE; LEARNING; MEMORY; PLACEBOS; RECEPTORS, N-METHYL-D-ASPARTATE; REFERENCE VALUES; SPACE PERCEPTION; SWIMMING;

EID: 13944263281     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300642     Document Type: Article

References (45)

1. Adler CM, Goldberg TE, Malhotra AK, Pickar D, Breier A. (1998). Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry 43: 811-816.
2. Andreasen NC (1984). The Scale for the Assessment of Negative Symptoms. University of Iowa: Iowa City.
3. Astur RS, Mathalon DH, D'Souza DC, Krystal JH, St. Germain S, Constable RT et al (2003). Using virtual reality to examine hippocampus functioning in schizophrenia. International Workshop on Virtual Rehabilitation Proceedings; September 21-22; Rutgers University, Piscataway, NJ.
4. Astur RS, Ortiz ML, Sutherland RJ (1998). A characterization of performance by men and women in a virtual Morris water task: a large and reliable sex difference. Behav Brain Res 93: 185-190.
5. Astur RS, Taylor LB, Mamelak AN, Philpott L, Sutherland RJ (2002). Human with hippocampus damage display severe spatial memory impairments in a virtual morris water task. Behav Brain Res 132: 77-84.
6. Bannerman DM, Good MA, Butcher SP, Ramsay M, Morris RGM (1995). Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature 378: 182-186.
7. Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS et al (1998). Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress 11: 125-136.
8. Coyle JT, Tsai G, Goff D (2003). Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann NY Acad Sci 1003: 318-327.
9. First MB, Spitzer RL, Gibbon M, Williams JBW (1995). Structured Clinical Interview for DSM-IV Axis I Disorders, Non-Patient Edition (SCID-NP), version 2. New York State Psychiatric Institute, Biometrics Research: New York.
10. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA (2000). Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 157: 1141-1149.
11. Ghoneim M, Hinrichs JV, Mewaldt SP, Peterson RC (1985). Ketamine: behavioural effects at subanesthetic doses. J Clin Psychopharmacol 5: 70-77.
12. Hamilton DA, Driscoll I, Sutherland RJ (2002). Human place learning in a virtual Morris water task: some important constraints on the flexibility of place navigation. Behav Brain Res 129: 159-170.
13. Harborne GC, Watson FL, Healy DT, Groves L (1996). The effects of sub-anaesthetic doses of ketamine on memory, cognitive performance and subjective experience in healthy volunteers. J Psychopharmacol 10: 134-140.
14. Harrison PJ, Law AJ, Eastwod SL (2003). Glutamate receptors and transporters in the hippocampus in schizophrenia. Ann NY Acad Sci 1003: 94-101.
15. Heinrichs RW, Zakzanis KK (1998). Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12: 426-445.
16. Hetem LAB, Danion JM, Diemunsch P, Brandt C (2000). Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology 152: 283-288.
17. Holthausen EAE, Wiersma D, Sitskoorn MM, Dingemans PM, Schene AH, Bosch RJ (2003). Long-term memory deficits in schizophrenia: primary or secondary dysfunction? Neuropsychology 17: 539-547.
18. Honey RAE, Turner DC, Honey GD, Sharar SR, Kumaran D, Pomarol-Clotet E et al (2003). Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory. Neuropsychopharmacology 28: 2037-2044.
19. Kant GJ, Wright WL, Robinson III TN, D'Angelo CP (1991). Effects of MK-801 on learning and memory as assessed using a novel water task. Pharmacol Biochem Behav 39: 479-485.
20. Krystal JH, Bennett A, Abi-Saab D, Beiger A, Karper LP, D'Souza DC et al (2000). Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions. Biol Psychiatry 47: 137-143.
21. Krystal JH, D'Souza DC, Karper LP, Bennett A, Abi-Dargham A, Abi-Saab D et al (1999). Interactive effects of subanesthetic ketamine and haloperidol. Psychopharmacology 145: 193-204.
22. Krystal JH, D'Souza DC, Mathalon D, Belger PE, Hoffman R (2003). NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology 169: 215-233.
23. Krystal JH, Karper LP, Bennett A, D'Souza DC, Abi-Dargham A, Morrisey K et al (1998). Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology 135: 213-299.
24. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214.
25. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA (1995a). Ketamine activated psychosis and alters limbic flow in schizophrenia. NeuroReport 6: 869-872.
26. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995b). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9-19.
27. Lezak MD (1995). Neuropsychological Assessment. Oxford University Press: New York.
28. Malhotra AK, Finals DA, Adler CM, Elman I, Clifton A, Pickar D et al (1997). Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17: 141-150.
29. Malhotra AK, Finals DA, Weingartner H, Sirocco K, Missar CD, Pickar D et al (1996). NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14: 301-307.
30. McLamb RL, Williams LR, Nanry KP, Wilson WA, Tilson HA (1990). MK-801 impedes the acquisition of a spatial memory task in rats. Pharmacol Biochem Behav 37: 41-45.
31. Morgan CJA, Mofeez A, Brandner B, Bromley L, Curran HV (2004). Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology 29: 208-218.
32. Morris RGM (1981). Spatial localization does not require the presence of local cues. Learn Motiv 12: 239-269.
33. Morris RGM, Davis M (1994). The role of NMDA receptors in learning and memory. In: Collingridge GL, Watkins JC (eds). The NMDA Receptor, 2nd edn. Oxford University Press: New York.
34. Nakazawa K, McHugh TJ, Wilson MA, Tonegawa S (2004). NMDA receptors, place cells, and hippocampal spatial memory. Nat Rev Neurosci 5: 361-372.
35. Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T et al (1999). Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20: 106-118.
36. Newcomer JW, Krystal JH (2001). NMDA receptor regulation of memory and behavior in humans. Hippocampus 11: 529-542.
37. Olney JW, Farber NB (1995). Glutamate receptor dysfunction in schizophrenia. Arch Gen Psychiatry 52: 998-1007.
38. Oranje B, van Berckel BNM, Kemner C, van Ree JM, Kahn RS, Verbaten MN (2000). The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology 22: 293-302.
39. Overall JF, Gorham DR (1962). The brief psychiatric rating scale. Psychol Rep 10: 799-812.
40. Rowland LM, Bustillo JR, Mullins PGM, Jung RE, Lenroot R, Landgraf E et al (2005). The effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4.0-T Proton MRS Study. Am J Psychaitry 162 (in press).
41. Sandstrom NJ, Kaufman J, Huettel SA (1998). Males and females use different distal cues in a virtual environment navigation task. Brain Res Cogn Brain Res 6: 351-360.
42. Saucier D, Cain DP (1995). Spatial learning without NMDA receptor-dependent long-term potentiation. Nature 378: 186-189.
43. Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, Resnick SM et al (1991). Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch Gen Psychiatry 48: 618-624.
44. Saykin AJ, Shtasel DL, Gur RE, Rester DB, Mozley LH, Stafiniak P et al (1994). Neuropsychological deficits in neuroleptic naïve patients with first-episode schizophrenia. Arch Gen Psychiatry 51: 124-131.
45. Tsien JZ, Heurta PT, Tonegawa S (1996). The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87: 1327-1338.